GlobalData on MSN12d
Rigel enrols first subject in Phase I sickle cell disease therapy trial
Rigel Pharmaceuticals has enrolled the first subject in a Phase I trial of its oral spleen tyrosine kinase (SYK) inhibitor, ...
drugtargetreview.com12d
First patient enrolled in fostamatinib trial for sickle cell disease
Rigel Pharmaceuticals has enrolled the first patient in a Phase I trial to evaluate fostamatinib as a treatment for sickle ...
Rigel Pharmaceuticals enrolls first patient in Phase 1 study of fostamatinib
Rigel Pharmaceuticals (RIGL) announced the first patient has been enrolled in a Phase 1 study evaluating the safety and tolerability of ...